The $3.4 Billion Lesson Pharma Faces in Shelved Drugs
Thousands of shelved drug candidates could unlock therapies for rare diseases, but funding and partnerships lag. The ...
Understanding when points offer greater value than cash back can enhance your credit card strategy. Discover these key moments.
28,161 articlesThousands of shelved drug candidates could unlock therapies for rare diseases, but funding and partnerships lag. The ...
When a juggernaut like Fortnite cools its engagement, the ripple effect hits the entire company. This piece digs into...
Oklo stock climbing higher this week is driven by regulatory progress on its Aurora reactor and broader interest in a...
Japan’s Toto, the top bidet maker, has long supplied precision chip components. Now investors are connecting Toto to ...
Anthropic filed confidentially for an IPO on June 1, 2026, signaling a landmark tech debut. For individual investors,...
A forum proposal from the founder of Kleros would allow Ethereum validators to redirect up to 10% of staking rewards ...
SoundHound AI releases its latest quarterly results, prompting a brisk market response as investors weigh growth pros...
When romance hits the headlines, money often follows in unexpected ways. This article breaks down practical money tip...
Investors are expanding beyond Vanguard in March 2026 as cost, access, and tool diversity drive choice. This report h...
Two leading retirement voices clash over Social Security timing, highlighting a debate that could determine six-figur...
Valero Energy and Baker Hughes surge in 2026 on oil strength and refining margins, while First Solar pivots lower ami...
Stocks paused after a sharp tech selloff, led by Micron and Intel. Yet one tech name stood out, bucking the trend as ...